Depyrogenated Sterile Empty Vials Market Research Report - Forecast to 2029 (Includes Business Impact of COVID-19)

                                          
Abstract, Snapshot, Market Analysis & Market Definition: Depyrogenated Sterile Empty Vials Market 
Industry / Sector Trends

Depyrogenated sterile empty vials market size was valued at 6.0 billion in 2018 and is expected to witness 4.7% CAGR from 2019 to 2025.

U.S.
Market Segmentation, Outlook & Regional Insights: Depyrogenated Sterile Empty Vials Market

Depyrogenated Sterile Empty Vials Market, By Product, 2018 & 2025 (USD Million)

Technological advancements in vial manufacturing process and launch of innovative vials will render positive impact on depyrogenated sterile empty vials market growth. Focus of industry players on development of affordable vials is expected to favour business growth. Development of innovative platform for fully integrated ready-to-use solution for aseptic manufacturing is expected to boost depyrogenated sterile empty vials industry growth during the analysis period.

Growing demand of compounding labs for creating personalized medicine in developed economies will drive depyrogenated sterile empty vials market. Convenience and benefits offered by compounding labs such as ability to compound medications that are not produced commercially proves beneficial for industry growth. Additionally, it specifically formulates liquid doses for patient with difficulty in swallowing pills that will accelerate the adoption of compounded drugs. Moreover, personalised medication prepared by compounding labs for corrective patient management can thus provide improved health outcomes for mainstream of patients thereby further augmenting the business growth. However, surging demand for other parenteral packaging alternatives may hinder depyrogenated empty vials market growth.

Depyrogenated Sterile Empty Vials Market, By Product

20ml vials segment held over 24% revenue share in 2018 and is anticipated to grow significantly by 2025. Ability of 20ml vials for storing samples and ideal for injectables packaging fosters the segmental growth. Usage of 20ml vials for decanting and transportation of small amounts of solvents accelerates the demand for such vials. Additionally, increasing adoption of 20ml vials in various clinical and research laboratories should boost business growth.

2ml vials segment is projected to witness exponential CAGR of more than 4% over the forthcoming years. Benefits offered by 2ml vials such as convenient storage of solutions, useful for sample collection and open cap design for ease of testing encourage customer preference that should upsurge the segment revenue size. Moreover, these vials are useful for testing solubility or dispersibility of materials that will increase its demand in coming years.

Depyrogenated Sterile Empty Vials Market, By End-use

Pharmaceutical manufacturers segment held over 31% revenue share in 2018 and will exhibit tremendous growth during the forecast timeline. Increasing storage of drugs such as emergency medicines and oncology coupled with high quality manufacturing units will favor the segmental growth.

Clinical labs segment was valued more than USD 1 billion in 2018 due to increasing usage of sterile vials in clinical settings. Increasing number of pharmaceutical and biotechnology projects will enhance the demand for clinical laboratories thereby fostering the segmental growth. Increasing use of depyrogenated sterile vials in clinical labs for efficient sample storage will foster segmental growth over the analysis period.

Germany Depyrogenated Sterile Empty Vials Market Size, By End-use, 2018 (USD Million)

Depyrogenated Sterile Empty Vials Market, By Region

North America depyrogenated sterile empty vials market will witness around 4% growth during the forecast timeframe. Rising prevalence of communicable and non-communicable diseases in the region is key factor driving depyrogenated sterile empty vials business growth over the coming years. Strong foothold of major business players in North America will further boost regional growth.

Asia Pacific market was valued more than USD 1.4 billion revenue in 2018. Regional growth can be attributed to rapidly increasing infectious diseases such as HIV. Moreover, changing lifestyle and rising prevalence of risk factors in the region will favor business growth. Growing number of research laboratories and clinical settings should further drive Asia Pacific depyrogenated sterile empty vials industry growth over the coming years.

Asia Pacific Depyrogenated Sterile Empty Vials Market Size, By Country, 2025 (USD Million)

Key Players, Recent Developments & Sector Viewpoints: Depyrogenated Sterile Empty Vials Market

Prominent industry players operating in depyrogenated sterile empty vials market include APG Pharma, Corning, DWK Life Sciences, Gerresheimer, NIPRO, Radpharm Scientific, Merck, SCHOTT, Stevanato, SGD Pharma, Thermo Fisher Scientific and VWR International. These industry players implement various strategies such as collaborations, acquisition and novel product launch to withstand in market and sustain industry competition. For instance, in July 2017, Gerresheimer collaborated with Corning Incorporated. This strategy aimed at delivering new corning Valor glass to the pharmaceutical packaging market. Valors superior strength and chemical durability result in better protection for drug products. This strategy enabled company to enhance its product portfolio.

Depyrogenated Sterile Empty Vials Industry Viewpoint

Packaging pharmaceutical products is a broad multi-faceted and encompassing task. It differs substantially from other packaging and is challenging and requires the application of large amount of scientific as well as engineering expertise to deliver a product. It focuses on information and knowledge from a wide range of scientific disciplines, including chemistry, material science, physical testing and engineering among others. Various companies operating in this industry focus on delivering different sizes and shapes of vials such as 2ml, 10ml and 40ml among others. Focus of industry players on introduction of novel and advanced vials have led to launch of various depyrogenated sterile empty vials over the recent years. Market players such as Gerresheimer, Stevanato, SGD pharma, Thermo Fisher Scientific and others are focusing their efforts in R&D for development of technologically advanced vials manufacturing platform. Increasing demand for depyrogenated sterile empty vials in various research laboratories and clinical settings will further drive industry growth during the forthcoming years

Key Insights Covered: Exhaustive Depyrogenated Sterile Empty Vials Market

1. Market size (sales, revenue and growth rate) of Depyrogenated Sterile Empty Vials industry.
2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Depyrogenated Sterile Empty Vials industry.
3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Depyrogenated Sterile Empty Vials industry.
4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Depyrogenated Sterile Empty Vials industry.

Research Methodology: Depyrogenated Sterile Empty Vials Market

  
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  
Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.